Skip to main content
INOVIQ LTD logo

INOVIQ LTD — Investor Relations & Filings

Ticker · IIQ ISIN · AU0000196149 ASX Professional, scientific and technical activities
Open in API
Filings indexed 858 across all filing types
Latest filing 2023-11-28 Declaration of Voting R…
Country AU Australia
Listing ASX IIQ

About INOVIQ LTD

https://www.inoviq.com

INOVIQ LTD specializes in the development and commercialization of next-generation exosome and precision diagnostics. The company focuses on innovative solutions for the early detection and monitoring of cancer and other diseases. Its proprietary technology portfolio includes EXO-NET, a high-throughput exosome capture tool designed for research and clinical applications, and the SubB2M platform, which utilizes an engineered protein to detect the pan-cancer biomarker Neu5Gc. The company also provides the hTERT test for bladder cancer monitoring. These technologies facilitate non-invasive liquid biopsy tests aimed at improving patient outcomes through high sensitivity and specificity. The core business activities encompass the creation of diagnostic tools and research reagents for the global healthcare and life sciences sectors, emphasizing precision medicine and early intervention.

Recent filings

Filing Released Lang Actions
2023 AGM Results of Meeting 2 pages 384.9KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled 'RESULTS OF ANNUAL GENERAL MEETING' and details the voting results of resolutions passed at the 2023 AGM of INOVIQ Limited. It references compliance with the Corporations Act 2001 and ASX Listing Rule 3.13.2, which govern shareholder meetings and voting disclosures. The content includes proxy votes, resolution outcomes, and meeting details, but does not contain financial statements or detailed financial analysis. The document length is 4600 characters, which is relatively short and focused on meeting results rather than a full report. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at general meetings. Therefore, the correct classification is DVA with high confidence.
2023-11-28 English
Bell Potter Healthcare Conference Investor Presentation 21 pages 1.4MB
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and includes detailed information about the company's technology, pipeline, management team, financial snapshot, and clinical validation studies. It is structured as a presentation for investors, focusing on company strategy, products, and market positioning. There is no indication that this is a formal regulatory filing, annual or interim report, or earnings release. The length (15,000 characters) and content are consistent with an investor presentation rather than a brief announcement or certification. Therefore, the document fits the category of an Investor Presentation (IP).
2023-11-15 English
ANSEV Meeting Presentations 4 pages 2.2MB
AGM Information Classification · 95% confidence The document is a detailed presentation of scientific poster materials related to INOVIQ Limited's technology and research findings, specifically for the Annual Meeting of the Australia and New Zealand Society for Extracellular Vesicles (ANSEV). It includes extensive scientific data, experimental results, and technical descriptions of their exosome isolation technology. The document is titled as meeting presentations and contains detailed scientific content rather than a brief announcement or summary. It is not a financial report, regulatory filing, or announcement of voting results. The content aligns with materials typically shared at scientific or annual meetings to inform attendees and stakeholders about research progress and innovations. Therefore, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during an Annual General Meeting or similar scientific meetings.
2023-11-07 English
Notification of cessation of securities - IIQ 4 pages 23.8KB
Regulatory Filings Classification · 95% confidence The document is a notification about the cessation of securities, specifically options that have lapsed due to conditions not being met. It includes details about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement related to changes in the company's securities, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis. This type of document fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit into more specific categories.
2023-11-02 English
Appendix 4C and Quarterly Activities Report - September 2023 10 pages 574.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'APPENDIX 4C & QUARTERLY BUSINESS UPDATE Period Ended 30 September 2023' and contains detailed financial and operational information for the quarter ended 30 September 2023. It includes cash balances, cash receipts, operating cash flows, R&D expenditure, and other financial metrics typical of a quarterly report. The length is substantial (15,000 characters), and it contains substantive financial data and business updates, not just an announcement or a certification. The presence of quarterly period dates and detailed financial and operational data confirms this is an Interim / Quarterly Report (IR). Q1 2024
2023-10-29 English
Notice of Annual General Meeting/Proxy Form 24 pages 519.0KB
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' for INOVIQ Limited, detailing the date, location, and procedures for the AGM. It includes the agenda items such as consideration of the Annual Report for the financial year ended 30 June 2023, adoption of the Remuneration Report, election and re-election of directors, approval of share issuance capacity, and issuance of options to a director. The document is a formal notice inviting shareholders to attend and vote at the AGM, including proxy voting instructions and voting eligibility. It does not contain the actual Annual Report or financial statements but references them and provides information on how to access them. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting, specifically the notice and agenda for the meeting. The document length (15,000 characters) and content confirm it is not a brief announcement but a full AGM notice.
2023-10-26 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.